Physician profile
Samuel C Lau
NPI 1730526260
$1,155.21
in general payments reported to CMS, 2019-2025
10 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Geriatric Psychiatry provider received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $96.50 · 2021: $37.49 · 2022: $289 · 2023: $253 · 2024: $85.46 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $538.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $254.24 | 2019-2024 | Invega Sustenna |
| Alkermes, INC. | $218.89 | 2019-2025 | Aristada, Lybalvi, Aristada Initio |
| Abbvie INC. | $155.67 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $136.43 | 2019-2025 | Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $129.16 | 2020-2025 | Uzedy |
| E.R. Squibb & Sons, L.L.C. | $75.33 | 2025 | Cobenfy |
| Lundbeck LLC | $54.38 | 2019-2023 | Abilify Maintena |
| Neurocrine Biosciences, INC. | $48.92 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $48.89 | 2023-2024 | Caplyta |
| Abbott Laboratories | $33.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Lau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.